Jeroen B. van Beek - 08 Nov 2022 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role
Chief Commercial Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
08 Nov 2022
Net transactions value
-$107,293
Form type
4
Filing time
10 Nov 2022, 16:29:58 UTC
Previous filing
26 Oct 2022
Next filing
15 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $2,392 -299 -0.07% $8.00 399,501 08 Nov 2022 Direct F1
transaction ALVR Common Stock Sale $104,901 -13,109 -3.3% $8.00 386,392 10 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 4, 2022.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.